Merck Limited - Chennai
Chennai, Tamil Nadu
About Company
Description
At Merck, we're following the science to tackle some of the world's greatest health threats. Get a glimpse of how we work to improve lives.
Contact Information
Primary Phone
Primary Email
Website
Registered Address
Full Address
SIPCOT, Sriperumbudur
City
Chennai
State
Tamil Nadu
Pincode
602105
Country
India
Business Information
Business Types
Manufacturer
PCD Franchisor
Exporter
Manufacturing Units
1
Legal & Compliance
Certifications & Approvals
WHO-GMP
Certified
ISO
Not Certified
GMP
Not Certified
FSSAI
Not Certified
USFDA
Not Approved
EU-GMP
Not Certified
UK-MHRA
Not Approved
WHO Prequalified
No
PCD/Franchise Information
PCD Franchisor
Yes
Products
This company has 196 products. Showing first 100 products below.
| Product Name | Dosage Form | Composition | Therapeutic Category |
|---|---|---|---|
| ADE VALLEE® (multivitamin) Injection Multivitamin (with Soy Oil) Formulation Canada - English Canada - French_CA USA - English USA - Spanish_MX Trademarks appearing on this website are owned, licensed | Injection | - | Vitamins |
| ADE VALLEE® (multivitamin) Injection Multivitamin (with Soy Oil) Formulation Canada - English Canada - French_CA USA - English USA - Spanish_MX Trademarks appearing on this website are owned, licensed | Injection | - | Vitamins |
| ADEVIL® (multivitamin) Solution for Injection Multivitamin (with Sunflower Oil) Formulation Canada - English Canada - French_CA USA - English USA - Spanish_MX Trademarks appearing on this website are | Injection | - | Vitamins |
| ADEVIL® (multivitamin) Solution for Injection Multivitamin (with Sunflower Oil) Formulation Canada - English Canada - French_CA USA - English USA - Spanish_MX Trademarks appearing on this website are | Injection | - | Vitamins |
| ALBIPEN® (ampicillin) Suspension Ampicillin Formulation Canada - English Canada - French_CA USA - English USA - Spanish_MX Trademarks appearing on this website are owned, licensed to, promoted or dist | Suspension | - | - |
| ALBIPEN® (ampicillin) Suspension Ampicillin Formulation Canada - English Canada - French_CA USA - English USA - Spanish_MX Trademarks appearing on this website are owned, licensed to, promoted or dist | Suspension | - | - |
| AMPROVIL® 60% (amprolium) Powder for Oral Solution Amprolium Solid Formulation Canada - English Canada - French_CA USA - English USA - Spanish_MX Trademarks appearing on this website are owned, licens | Powder | - | - |
| AMPROVIL® 60% (amprolium) Powder for Oral Solution Amprolium Solid Formulation Canada - English Canada - French_CA USA - English USA - Spanish_MX Trademarks appearing on this website are owned, licens | Powder | - | - |
| Antistress Fish Multivitamin (with Starch) Formulation Canada - English Canada - French_CA USA - English USA - Spanish_MX Trademarks appearing on this website are owned, licensed to, promoted or distr | - | - | Vitamins |
| Antistress Fish Multivitamin (with Starch) Formulation Canada - English Canada - French_CA USA - English USA - Spanish_MX Trademarks appearing on this website are owned, licensed to, promoted or distr | - | - | Vitamins |
| Aqua C® Fish Plus Vitamin C (>10%) Formulation Canada - English Canada - French_CA USA - English USA - Spanish_MX Trademarks appearing on this website are owned, licensed to, promoted or distributed b | - | - | Vitamins |
| Aqua C® Fish Plus Vitamin C (>10%) Formulation Canada - English Canada - French_CA USA - English USA - Spanish_MX Trademarks appearing on this website are owned, licensed to, promoted or distributed b | - | - | Vitamins |
| Aqua C® Vitamin C Formulation Canada - English Canada - French_CA USA - English USA - Spanish_MX Trademarks appearing on this website are owned, licensed to, promoted or distributed by MSD, its subsid | - | - | Vitamins |
| Aqua C® Vitamin C Formulation Canada - English Canada - French_CA USA - English USA - Spanish_MX Trademarks appearing on this website are owned, licensed to, promoted or distributed by MSD, its subsid | - | - | Vitamins |
| AQUAFEN-L® (florfenicol) In-feed Antibiotic Florfenicol (2%) Liquid Formulation Canada - English Canada - French_CA USA - English USA - Spanish_MX Trademarks appearing on this website are owned, licen | - | - | Antibiotics |
| AQUAFEN-L® (florfenicol) In-feed Antibiotic Florfenicol (2%) Liquid Formulation Canada - English Canada - French_CA USA - English USA - Spanish_MX Trademarks appearing on this website are owned, licen | - | - | Antibiotics |
| AQUAFEN-L™ (florfenicol) In-feed Antibiotic Florfenicol (2%) Liquid Formulation Canada - English Canada - French_CA USA - English USA - Spanish_MX Trademarks appearing on this website are owned, licen | - | - | Antibiotics |
| AQUAFEN-L™ (florfenicol) In-feed Antibiotic Florfenicol (2%) Liquid Formulation Canada - English Canada - French_CA USA - English USA - Spanish_MX Trademarks appearing on this website are owned, licen | - | - | Antibiotics |
| AROVYN® (tulathromycin) Solution for Injection Tulathromycin Formulation Canada - English Canada - French_CA USA - English USA - Spanish_MX Trademarks appearing on this website are owned, licensed to, | Injection | - | - |
| AROVYN® (tulathromycin) Solution for Injection Tulathromycin Formulation Canada - English Canada - French_CA USA - English USA - Spanish_MX Trademarks appearing on this website are owned, licensed to, | Injection | - | - |
| ATROVIL® (atropine sulfate) Solution for Injection Atropine Sulfate Formulation Canada - English Canada - French_CA USA - English USA - Spanish_MX Trademarks appearing on this website are owned, licen | Injection | - | - |
| ATROVIL® (atropine sulfate) Solution for Injection Atropine Sulfate Formulation Canada - English Canada - French_CA USA - English USA - Spanish_MX Trademarks appearing on this website are owned, licen | Injection | - | - |
| AVELOX® (moxifloxacin hydrochloride) Tablets Moxifloxacin Solid Formulation Canada - English Canada - French_CA USA - English USA - Spanish_MX Trademarks appearing on this website are owned, licensed | Tablet | - | - |
| AVELOX® (moxifloxacin hydrochloride) Tablets Moxifloxacin Solid Formulation Canada - English Canada - French_CA USA - English USA - Spanish_MX Trademarks appearing on this website are owned, licensed | Tablet | - | - |
| AVELOX® I.V. (moxifloxacin hydrochloride) Injection, Solution for IV Use Moxifloxacin Liquid Formulation Canada - English Canada - French_CA USA - English USA - Spanish_MX Trademarks appearing on this | Injection | - | - |
| AVELOX® I.V. (moxifloxacin hydrochloride) Injection, Solution for IV Use Moxifloxacin Liquid Formulation Canada - English Canada - French_CA USA - English USA - Spanish_MX Trademarks appearing on this | Injection | - | - |
| AZIUM® (dexamethasone) Intramuscular Solution for Injection Dexamethasone (with Ethanol) Formulation Canada - English Canada - French_CA USA - English USA - Spanish_MX Trademarks appearing on this web | Injection | - | - |
| AZIUM® (dexamethasone) Intramuscular Solution for Injection Dexamethasone (with Ethanol) Formulation Canada - English Canada - French_CA USA - English USA - Spanish_MX Trademarks appearing on this web | Injection | - | - |
| AZIUM® (dexamethasone) Tablets Dexamethasone Solid Formulation Canada - English Canada - French_CA USA - English USA - Spanish_MX Trademarks appearing on this website are owned, licensed to, promoted | Tablet | - | - |
| AZIUM® (dexamethasone) Tablets Dexamethasone Solid Formulation Canada - English Canada - French_CA USA - English USA - Spanish_MX Trademarks appearing on this website are owned, licensed to, promoted | Tablet | - | - |
| B BCG Vaccine (For Percutaneous Use) Prescribing Information Instructions for Use BELSOMRA® (suvorexant) tablets, for oral use, C-IV Prescribing Information Medication Guide Product website BRIDION® ( | Tablet | - | - |
| B BCG Vaccine (For Percutaneous Use) Prescribing Information Instructions for Use BELSOMRA® (suvorexant) tablets, for oral use, C-IV Prescribing Information Medication Guide Product website BRIDION® ( | Tablet | - | - |
| BCG Vaccine (For Percutaneous Use) Prescribing Information Instructions for Use BELSOMRA® (suvorexant) tablets, for oral use, C-IV Prescribing Information Medication Guide Product website BRIDION® (su | Tablet | - | - |
| BCG Vaccine (For Percutaneous Use) Prescribing Information Instructions for Use BELSOMRA® (suvorexant) tablets, for oral use, C-IV Prescribing Information Medication Guide Product website BRIDION® (su | Tablet | - | - |
| BELSOMRA® (suvorexant) Tablet for Oral Use Suvorexant Formulation Canada - English Canada - French_CA USA - English USA - Spanish_MX Trademarks appearing on this website are owned, licensed to, promot | Tablet | - | - |
| BELSOMRA® (suvorexant) Tablet for Oral Use Suvorexant Formulation Canada - English Canada - French_CA USA - English USA - Spanish_MX Trademarks appearing on this website are owned, licensed to, promot | Tablet | - | - |
| BELSOMRA® (suvorexant) Tablets U.S. Patent No. 7,951,797 U.S. Patent No. 10,098,892 | Tablet | - | - |
| BELSOMRA® (suvorexant) Tablets U.S. Patent No. 7,951,797 U.S. Patent No. 10,098,892 | Tablet | - | - |
| BELSOMRA® (suvorexant) tablets, for oral use, C-IV Prescribing Information Medication Guide Product website | Tablet | - | - |
| BELSOMRA® (suvorexant) tablets, for oral use, C-IV Prescribing Information Medication Guide Product website | Tablet | - | - |
| BELSOMRA® (suvorexant) Tablets, for Oral Use, C-IV Suvorexant Formulation Canada - English Canada - French_CA USA - English USA - Spanish_MX Trademarks appearing on this website are owned, licensed to | Tablet | - | - |
| BELSOMRA® (suvorexant) Tablets, for Oral Use, C-IV Suvorexant Formulation Canada - English Canada - French_CA USA - English USA - Spanish_MX Trademarks appearing on this website are owned, licensed to | Tablet | - | - |
| BOOSTIN® (recombinant bovine somatotropin) Sustained-Release Injection Recombinant Bovine Somatotropin Formulation Canada - English Canada - French_CA USA - English USA - Spanish_MX Trademarks appeari | Injection | - | - |
| BOOSTIN® (recombinant bovine somatotropin) Sustained-Release Injection Recombinant Bovine Somatotropin Formulation Canada - English Canada - French_CA USA - English USA - Spanish_MX Trademarks appeari | Injection | - | - |
| BRAVECTO QUANTUM FLURALANER 150 mg/mL INJECTABLE SUSPENSION FOR DOGS Fluralaner Canada - English Canada - French_CA USA - English USA - Spanish_MX Trademarks appearing on this website are owned, lice | Suspension | - | - |
| BRAVECTO QUANTUM FLURALANER 150 mg/mL INJECTABLE SUSPENSION FOR DOGS Fluralaner Canada - English Canada - French_CA USA - English USA - Spanish_MX Trademarks appearing on this website are owned, lice | Suspension | - | - |
| BRIDION® (sugammadex sodium injection) For intravenous use U.S. Patent No. RE44,733 | Injection | - | - |
| BRIDION® (sugammadex sodium injection) For intravenous use U.S. Patent No. RE44,733 | Injection | - | - |
| BRIDION® (sugammadex) Injection, for intravenous use Prescribing Information | Injection | - | - |
| BRIDION® (sugammadex) Injection, for intravenous use Prescribing Information | Injection | - | - |
| BRIDION® (sugammadex) Solution for Injection Sugammadex Formulation Canada - English Canada - French_CA USA - English USA - Spanish_MX Trademarks appearing on this website are owned, licensed to, prom | Injection | - | - |
| BRIDION® (sugammadex) Solution for Injection Sugammadex Formulation Canada - English Canada - French_CA USA - English USA - Spanish_MX Trademarks appearing on this website are owned, licensed to, prom | Injection | - | - |
| C CANCIDAS® (caspofungin acetate) for Injection, for intravenous use Prescribing Information CAPVAXIVE™ (Pneumococcal 21 valent Conjugate Vaccine) Prescribing Information Patient Product Information | Injection | - | - |
| C CANCIDAS® (caspofungin acetate) for Injection, for intravenous use Prescribing Information CAPVAXIVE™ (Pneumococcal 21 valent Conjugate Vaccine) Prescribing Information Patient Product Information | Injection | - | - |
| CANCIDAS® (caspofungin acetate) for Injection, for intravenous use Prescribing Information | Injection | - | - |
| CANCIDAS® (caspofungin acetate) for Injection, for intravenous use Prescribing Information | Injection | - | - |
| CANCIDAS® (caspofungin acetate) for Injection, for intravenous use Prescribing Information CAPVAXIVE™ (Pneumococcal 21 valent Conjugate Vaccine) Prescribing Information Patient Product Information | Injection | - | - |
| CANCIDAS® (caspofungin acetate) for Injection, for intravenous use Prescribing Information CAPVAXIVE™ (Pneumococcal 21 valent Conjugate Vaccine) Prescribing Information Patient Product Information | Injection | - | - |
| CAPVAXIVE™ PNEUMOCOCCAL 21-VALENT CONJUGATE VACCINE Injection, for intramuscular use U.S. Patent No. 11,116,828 | Injection | - | - |
| CAPVAXIVE™ PNEUMOCOCCAL 21-VALENT CONJUGATE VACCINE Injection, for intramuscular use U.S. Patent No. 11,116,828 | Injection | - | - |
| D DELSTRIGO® (doravirine, lamivudine, and tenofovir disoproxil fumarate) tablets, for oral use Prescribing Information Patient Product Information DIFICID® (fidaxomicin) for Oral Suspension DIFICID® ( | Tablet | - | - |
| D DELSTRIGO® (doravirine, lamivudine, and tenofovir disoproxil fumarate) tablets, for oral use Prescribing Information Patient Product Information DIFICID® (fidaxomicin) for Oral Suspension DIFICID® ( | Tablet | - | - |
| DELSTRIGO® (doravirine, lamivudine, and tenofovir disoproxil fumarate) tablets, for oral use Prescribing Information Patient Product Information | Tablet | - | - |
| DELSTRIGO® (doravirine, lamivudine, and tenofovir disoproxil fumarate) tablets, for oral use Prescribing Information Patient Product Information | Tablet | - | - |
| DELSTRIGO® (doravirine, lamivudine, and tenofovir disoproxil fumarate) tablets, for oral use Prescribing Information Patient Product Information DIFICID® (fidaxomicin) for Oral Suspension DIFICID® (fi | Tablet | - | - |
| DELSTRIGO® (doravirine, lamivudine, and tenofovir disoproxil fumarate) tablets, for oral use Prescribing Information Patient Product Information DIFICID® (fidaxomicin) for Oral Suspension DIFICID® (fi | Tablet | - | - |
| DELSTRIGO® (doravirine/lamivudine/tenofovir disoproxil fumarate) Tablets U.S. Patent No. 8,486,975 U.S. Patent No. 10,603,282 U.S. Patent No. 10,842,751 | Tablet | - | - |
| DELSTRIGO® (doravirine/lamivudine/tenofovir disoproxil fumarate) Tablets U.S. Patent No. 8,486,975 U.S. Patent No. 10,603,282 U.S. Patent No. 10,842,751 | Tablet | - | - |
| DIFICID® (fidaxomicin) for Oral Suspension DIFICID® (fidaxomicin) tablets, for oral use Prescribing Information Patient Product Information | Tablet | - | - |
| DIFICID® (fidaxomicin) for Oral Suspension DIFICID® (fidaxomicin) tablets, for oral use Prescribing Information Patient Product Information | Tablet | - | - |
| DIFICID® (fidaxomicin) for Oral Suspension U.S. Patent No. 7,863,249 U.S. Patent No. 7,378,508 U.S. Patent No. 9,808,530 | Suspension | - | - |
| DIFICID® (fidaxomicin) for Oral Suspension U.S. Patent No. 7,863,249 U.S. Patent No. 7,378,508 U.S. Patent No. 9,808,530 | Suspension | - | - |
| DIFICID® (fidaxomicin) Tablets for oral use U.S. Patent No. 7,863,249 U.S. Patent No. 7,378,508 | Tablet | - | - |
| DIFICID® (fidaxomicin) Tablets for oral use U.S. Patent No. 7,863,249 U.S. Patent No. 7,378,508 | Tablet | - | - |
| E EMEND® (aprepitant) capsules (aprepitant) for oral suspension Prescribing Information Patient Product Information Instructions for Use EMEND® (fosaprepitant) for injection, for intravenous use Presc | Capsule | - | - |
| E EMEND® (aprepitant) capsules (aprepitant) for oral suspension Prescribing Information Patient Product Information Instructions for Use EMEND® (fosaprepitant) for injection, for intravenous use Presc | Capsule | - | - |
| efinopegdutide(MK-6024)Metabolic dysfunction-associated steatohepatitis(NCT04944992;NCT06465186;NCT05877547;NCT06482112)Therapeutic area:EndocrinologyMechanism of Action:Efinopegdutide is an investiga | Tablet | - | - |
| efinopegdutide(MK-6024)Metabolic dysfunction-associated steatohepatitis(NCT04944992;NCT06465186;NCT05877547;NCT06482112)Therapeutic area:EndocrinologyMechanism of Action:Efinopegdutide is an investiga | Tablet | - | - |
| EMEND® (aprepitant) capsules (aprepitant) for oral suspension Prescribing Information Patient Product Information Instructions for Use | Capsule | - | - |
| EMEND® (aprepitant) capsules (aprepitant) for oral suspension Prescribing Information Patient Product Information Instructions for Use | Capsule | - | - |
| EMEND® (aprepitant) capsules (aprepitant) for oral suspension Prescribing Information Patient Product Information Instructions for Use EMEND® (fosaprepitant) for injection, for intravenous use Prescri | Capsule | - | - |
| EMEND® (aprepitant) capsules (aprepitant) for oral suspension Prescribing Information Patient Product Information Instructions for Use EMEND® (fosaprepitant) for injection, for intravenous use Prescri | Capsule | - | - |
| EMEND® (aprepitant) Capsules 125/80 mg U.S. Patent No. 8,258,132 | Capsule | - | - |
| EMEND® (aprepitant) Capsules 125/80 mg U.S. Patent No. 8,258,132 | Capsule | - | - |
| EMEND® (aprepitant) Capsules 40mg U.S. Patent No. 8,258,132 | Capsule | - | - |
| EMEND® (aprepitant) Capsules 40mg U.S. Patent No. 8,258,132 | Capsule | - | - |
| EMEND® (aprepitant) for oral suspension (125 mg) U.S. Patent No. 8,258,132 | Suspension | - | - |
| EMEND® (aprepitant) for oral suspension (125 mg) U.S. Patent No. 8,258,132 | Suspension | - | - |
| EMEND® (fosaprepitant) for injection, for intravenous use Prescribing Information Patient Product Information | Injection | - | - |
| EMEND® (fosaprepitant) for injection, for intravenous use Prescribing Information Patient Product Information | Injection | - | - |
| ENFLONSIA™ (clesrovimab-cfor) injection, for intramuscular use Prescribing Information Patient Product Information | Injection | - | - |
| ENFLONSIA™ (clesrovimab-cfor) injection, for intramuscular use Prescribing Information Patient Product Information | Injection | - | - |
| ensifentrine (+) glycopyrrolate(MK-5884A)COPD(NCT07132983)Therapeutic area:RespiratoryMechanism of Action:Ensifentrine (+) glycopyrrolate is a combination of a selective dual inhibitor of phosphodiest | - | ensifentrine (+) glycopyrrolate(MK-5884A)Mechanism... | - |
| ensifentrine (+) glycopyrrolate(MK-5884A)COPD(NCT07132983)Therapeutic area:RespiratoryMechanism of Action:Ensifentrine (+) glycopyrrolate is a combination of a selective dual inhibitor of phosphodiest | - | ensifentrine (+) glycopyrrolate(MK-5884A)Mechanism... | - |
| ERVEBO® (Ebola Zaire Vaccine, Live) Suspension for intramuscular injection Prescribing Information Patient Product Information | Injection | - | - |
| ERVEBO® (Ebola Zaire Vaccine, Live) Suspension for intramuscular injection Prescribing Information Patient Product Information | Injection | - | - |
| G GARDASIL® [Human Papillomavirus Quadrivalent (Types 6, 11, 16 and 18) Vaccine, Recombinant] Prescribing Information Patient Product Information GARDASIL®9 (Human Papillomavirus 9-valent Vaccine, Rec | Injection | - | - |
| G GARDASIL® [Human Papillomavirus Quadrivalent (Types 6, 11, 16 and 18) Vaccine, Recombinant] Prescribing Information Patient Product Information GARDASIL®9 (Human Papillomavirus 9-valent Vaccine, Rec | Injection | - | - |
| GARDASIL® [Human Papillomavirus Quadrivalent (Types 6, 11, 16 and 18) Vaccine, Recombinant] Prescribing Information Patient Product Information GARDASIL®9 (Human Papillomavirus 9-valent Vaccine, Recom | Injection | - | - |
| GARDASIL® [Human Papillomavirus Quadrivalent (Types 6, 11, 16 and 18) Vaccine, Recombinant] Prescribing Information Patient Product Information GARDASIL®9 (Human Papillomavirus 9-valent Vaccine, Recom | Injection | - | - |
Social Media
Twitter
Company Status
Status
Active
Verification
Verified
Statistics
Profile Views
81
Total Inquiries
0